[1]
Zerga, M. 2025. Bispecific antibodies in the treatment of relapsed/refractory diffuse large B cell lymphoma. Role of epcoritamab. Journal of Hematology. 29, 1 (Jun. 2025), 11–21. DOI:https://doi.org/10.48057/hematologa.v29i1.639.